Delivery Order SPE2DB20D3103-SPE2DB25FN5Q2

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,518,973 units of the pharmaceutical drug Dextroamp-Amphet ER 10 mg capsules. The contract has a completion date of February 2, 2024 and a potential value of $2,074.48. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,904,774 units of Dextroamphet-amphet ER 20 mg capsules in 100-count bottles. The total ceiling value of the contract is $1,936.07, with a firm fixed price. The contract has an ultimate completion date of August 22, 2023. This contract is not designated with a set-aside...
This federal contract award, valued at $1,722.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567458315 DEXTROAMP-AMPHET ER 10 MG CAP 100S, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of March 5, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp...
This is a $1,404.64 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567872102 ! DEXTROAMP-AMPHET ER 10 MG CAP 100S, with a performance period through April 9, 2025. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,919.14, is a delivery order for DEXTROAMP-AMPHET ER 20 MG CAP 100S, a prescription medication. The contract has a period of performance through December 4, 2024 and utilizes a firm fixed-price pricing structure. This award is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,449.40 firm fixed-price delivery order is for the supply of 4,562,967,887 units of Dextroamphetamine ER 10 mg capsules. The award has an ultimate completion date of December 4, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $3,064.80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the delivery of 4,564,001,392 units of the medication dextroamp-amphet ER 30 mg capsules, in 100-count bottles, with a period of performance through March 19, 2024. This is a firm fixed price delivery order contract, with no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,832.06, is for the delivery of 4567984776 DEXTROAMP-AMPHET ER 20 MG CAP 100S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the leading pharmaceutical distributor Amerisourcebergen Corporation. The $1,237.14 award is for the supply of 4,564,232,196 units of the drug Dextroamp-Amphet ER 25 mg capsules. This delivery order falls under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award, valued at $1,190.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB24D2100|SPE2DB25FBDRN) for the supply of 4567967859 DEXTROAMP-AMPHET ER 20 MG CAP 100S, with a firm fixed price and an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN5Q2
    Delivery Order

This federal contract award, valued at $1,044.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,028,081 units of the medication Dextroamp-Amphet ER 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract award is not designated as a set-aside and was open to competition. The contract allows Amerisourcebergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/23/25, 9:45 AM